PAPER Muir RT, Stukas S, Cooper JG, Beaudin AE, McCreary CR, Gee M, Nelles K, Nukala N, Valencia J, Kirmess KM, Black SE, Hill MD, Camicioli R, Wellington CL, Smith EE

Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls.

Alzheimers Dement. 2025 Mar;21(3):e70010. PubMed.

PAPER Rabinovici GD, Selkoe DJ, Schindler SE, Aisen P, Apostolova LG, Atri A, Greenberg SM, Hendrix SB, Petersen RC, Weiner M, Salloway S, Cummings J

Donanemab: Appropriate use recommendations.

J Prev Alzheimers Dis. 2025 Mar 27;:100150. Epub 2025 Mar 27 PubMed.

PAPER Donaghy PC, Hasoon J, Hamilton CA, Ciafone J, Durcan R, Barnett N, Olsen K, Lawley S, Greenfinch G, Firbank M, Heslegrave A, Zetterberg H, Allan L, O'Brien JT, Taylor JP, Thomas AJ

Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies.

Mov Disord. 2025 Mar 29; Epub 2025 Mar 29 PubMed.

PAPER Rehman H, Ang TF, Tao Q, Au R, Farrer LA, Qiu WQ, Zhang X, Alzheimer's Disease Neuroimaging Initiative

Plasma protein risk scores for mild cognitive impairment and Alzheimer's disease in the Framingham heart study.

Alzheimers Dement. 2025 Mar;21(3):e70066. PubMed.

PAPER Ribino P, Di Napoli C, Paragliola G, Chicco D, Gasparini F

Multivariate longitudinal clustering reveals neuropsychological factors as dementia predictors in an Alzheimer's disease progression study.

BioData Min. 2025 Mar 28;18(1):26. PubMed.

PAPER Ossenkoppele R, Salvadó G, Janelidze S, Pichet Binette A, Bali D, Karlsson L, Palmqvist S, Mattsson-Carlgren N, Stomrud E, Therriault J, Rahmouni N, Rosa-Neto P, Coomans EM, van de Giessen E, van der Flier WM, Teunissen CE, Jonaitis EM, Johnson SC, Villeneuve S, PREVENT-AD Research Group, Benzinger TL, Schindler SE, Bateman RJ, Doecke JD, Doré V, Feizpour A, Masters CL, Rowe C, Wiste HJ, Petersen RC, Jack CR Jr, Hansson O

Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials.

Nat Aging. 2025 Mar 28; Epub 2025 Mar 28 PubMed.

PAPER Jahng GH, Lee MB, Kwon OI

Gadolinium based contrast agent induced electrical conductivity heterogeneity analysis in the brain of Alzheimer's disease.

Sci Rep. 2025 Mar 28;15(1):10832. PubMed.

SEARCH RESULTS

Samantha Bozarth

Laura Rosen

Bacteria in the brain: do they have a role in the pathogenesis of Alzheimer's disease?

James Herndon

Cheng Hu

Xulin Li

Amyloidogenic and non-amyloidogenic pathways of amyloid precursor protein processing in oligodendrocytes.

Deep Brain Stimulation Improves Symptoms in an Individual with Alpha-Synuclein-Gene-Associated Parkinson's Disease.